BMO Capital Markets upgraded shares of Criteo (NASDAQ:CRTO – Free Report) from a market perform rating to an outperform rating in a research report released on Friday morning, Marketbeat.com reports. BMO Capital Markets currently has $45.00 target price on the information services provider’s stock, up from their previous target price of $31.00. Other equities analysts […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) has received a consensus rating of “Moderate Buy” from the seventeen brokerages that are currently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12 month price objective among […]
Cytokinetics (NASDAQ:CYTK – Free Report) had its price objective cut by Raymond James from $92.00 to $70.00 in a report published on Thursday morning, Benzinga reports. They currently have an outperform rating on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on CYTK. Mizuho reduced their price target on shares […]
Cytokinetics (NASDAQ:CYTK – Free Report) had its price target reduced by Barclays from $100.00 to $95.00 in a report issued on Thursday, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued reports about the company. HC Wainwright restated a buy rating and issued a $94.00 […]
Atlas Energy Solutions Inc. (NYSE:AESI – Get Free Report) major shareholder Chad M. Mcever sold 100,000 shares of the business’s stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $24.55, for a total value of $2,455,000.00. Following the transaction, the insider now owns 451,755 shares of the […]